choose content

Choose content

Enter keywords to create a newsletter
create account

Create account

Enter your registration information
set preferences

Set preferences

Set up your newsletter name, delivery and time zone preferences
Hint: Enter different keywords to generate new results.

Now you can:

  1. Search the news index.
  2. Browse more than 1 million newsletters by category.
  3. Use preset newsletters:
    • Amgen Assets

Amgen Assets Newsletter
  • Analyst Expectations For Amgen's Future 28 Jan 2025 13:29 GMT

    … date on Amgen analyst ratings. About Amgen Amgen is a … for inflammatory diseases. Amgen introduced its first cancer … biosimilar portfolio. Financial Insights: Amgen Market Capitalization: Positioned above … capital. Return on Assets (ROA): Amgen's ROA …

  • JPM25 Day Two: Roche, Amgen, Merck, Lilly and Biogen 15 Jan 2025 13:35 GMT

    … and when we find transformative assets that are either complementary to … the game in important diseases.” Amgen Doubles Down on MariTide Despite … Speaking to reporters on Tuesday, Amgen officials defended the Phase II …

  • Amgen: Blockbusters, Emerging Therapies, And Investment Potential 06 Jan 2025 02:53 GMT

    Summary Amgen's strong product … on BLINCYTO, but promising pipeline assets are expected to offset these … iStock via Getty Images Thesis Amgen Inc. (NASDAQ:AMGN) is a biotechnology powerhouse … position in the shares of AMGN either through stock ownership, …

  • Demystifying Amgen: Insights From 13 Analyst Reviews 10 Dec 2024 13:25 GMT

    … on Amgen analyst ratings. Get to Know Amgen Better Amgen … for inflammatory diseases. Amgen introduced its first cancer … portfolio. Financial Insights: Amgen Market Capitalization: Positioned above … effective utilization of assets. Debt Management: Amgen's …

  • Amgen's Weight-loss Drug Fails to Impress in Study; Shares Plunge 26 Nov 2024 14:17 GMT

    … P. Morgan analyst Chris Schott. Amgen said nausea and vomiting events … ($1.26 billion) in assets. Still, Amgen is betting on the drug … potentially 12 or fewer," Amgen's chief scientific … second gut hormone called GIP. Amgen's MariTide, while …

  • US close: Dow falls for fourth day, but Nvidia lifts Nasdaq 19 Nov 2024 22:45 GMT

    … investors rushed for safe-haven assets, rattled by escalating tensions between … providing a lift on the Nasdaq, jumping nearly 5% ahead of … ) $417.79 0.49% Amgen Inc. (AMGN) $279.95 0.43% Salesforce … . (CDNS) $299.70 1.83% Nasdaq 100 - Fallers Qurate Retail …

  • What’s Happening With Amgen Stock? 13 Nov 2024 16:07 GMT

    … /LightRocket via Getty Images Amgen stock (NASDAQ: AMGN) saw a 7% fall … the dosage for Amgen. Barring the recent decline, AMGN stock has fared … a percentage of assets of around 10%, we think Amgen looks reasonably …

  • BMS, Merck, Amgen and more must look to M&A to offset looming patent lapses: Leerink 13 Nov 2024 17:02 GMT

    … Bristol Myers Squibb, Merck, Amgen, Novartis and AstraZeneca are staring … acquirers of earlier-stage assets.” LOEs on the horizon … across all therapeutic areas.” Amgen faces the next greatest exposure … decade While BMS, Merck, Amgen, Novartis and AZ will …

  • Amgen Inc. (AMGN): Pioneering Healthcare Innovations in Obesity Treatment 14 Aug 2024 14:41 GMT

    … drug developed by the company. Amgen Inc. (NASDAQ:AMGN) Number of Hedge Fund … total assets and $10.9 billion in cash means that Amgen Inc. (NASDAQ:AMGN … from Amgen Inc. (NASDAQ:AMGN) is years away. Here’s what Amgen Inc. (NASDAQ:AMGN)’s …

  • Amgen Whets Investors’ Appetites for MariTide Obesity Data by End of Year 31 Oct 2024 13:02 GMT

    … . By contrast, Amgen’s top-selling assets Tepezza and Prolia … limited details” for the Amgen’s highly anticipated obesity candidate … portfolio, pointing out that Amgen provided only “incremental points” … more frustrated,” given that Amgen’s business will be …

Satisfied with the content?

Continue to create your account.